rivaroxaban and ASA

DRUG2 trials

Sponsors

David Anderson, McMaster University

Conditions

Cardiovascular PreventionHip Fracture SurgeryVenous ThromboembolismVenous Thromboembolism (VTE)

Phase 3

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty

CompletedNCT01720108

David AndersonVenous Thromboembolism

Start: 2013-02-24End: 2016-07-31Updated: 2018-01-25

Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention

Not yet recruitingNCT07228663

McMaster UniversityCardiovascular Prevention, Hip Fracture Surgery, Venous Thromboembolism (VTE)

Start: 2025-12-01End: 2027-12-01Target: 100Updated: 2025-11-14

Related Papers

Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty

New England Journal of Medicine2018-02-21427 citations